Cargando…

Circulating cell-free DNA is a predictor of short-term neurological outcome in stroke patients treated with intravenous thrombolysis

Circulating cell-free DNA (cfDNA) has been described as a prognostic marker for several diseases. Its prognostic value for short-term outcome in stroke patients treated with intravenous thrombolysis remains unexplored. cfDNA was measured on admission in 54 tissue plasminogen activator (tPA)-treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bustamante, Alejandro, Mancha, Fernando, Macher, Hada C, García-Berrocoso, Teresa, Giralt, Dolors, Ribó, Marc, Guerrero, Juan M, Montaner, Joan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548318/ https://www.ncbi.nlm.nih.gov/pubmed/28936264 http://dx.doi.org/10.1177/1849454416668791

Ejemplares similares

Characterization of the rat cerebrospinal fluid proteome following acute cerebral ischemia using an aptamer-based proteomic technology
por: Simats, Alba, et al.
Publicado: (2018)

Intravenous Thrombolysis in Posterior Circulation Stroke
por: Dorňák, Tomáš, et al.
Publicado: (2019)

Cardioembolic Stroke Diagnosis Using Blood Biomarkers
por: Llombart, VÍctor, et al.
Publicado: (2013)

Predictors of Early Neurological Deterioration Following Intravenous Thrombolysis: Difference between Risk Factors for Ischemic and Hemorrhagic Worsening
por: Nair, Srikumar B., et al.
Publicado: (2022)

Early neurological deterioration after intravenous thrombolysis of anterior vs posterior circulation stroke: a secondary analysis of INTRECIS
por: Cui, Yu, et al.
Publicado: (2022)

Influencing Factors of Early Neurological Deterioration and Short-Term Prognosis after Intravenous Thrombolysis in Patients with Acute Ischemic Stroke
por: Liu, Guangsheng, et al.
Publicado: (2021)

Meta-Analysis of Predictive Role of Early Neurological Deterioration after Intravenous Thrombolysis
por: Jiang, Haiwei, et al.
Publicado: (2022)

Analysis of influencing factors of early neurological improvement after intravenous rt-PA thrombolysis in acute anterior circulation ischemic stroke
por: Xiufu, Zhang, et al.
Publicado: (2022)

Usefulness of TNFR1 as biomarker of intracranial aneurysm in patients with spontaneous subarachnoid hemorrhage
por: de Torres, Reyes, et al.
Publicado: (2019)

Clinical and Magnetic Resonance Imaging Predictors of Very Early Neurological Response to Intravenous Thrombolysis in Patients With Middle Cerebral Artery Occlusion
por: Apoil, Marion, et al.
Publicado: (2013)

Retracted: Influencing Factors of Early Neurological Deterioration and Short-Term Prognosis after Intravenous Thrombolysis in Patients with Acute Ischemic Stroke
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Corticospinal Tract Hypoperfusion Associated With Unexplained Early Neurological Deterioration After Intravenous Thrombolysis
por: Zhang, Danfeng, et al.
Publicado: (2022)

Association of serum biomarkers with early neurologic improvement after intravenous thrombolysis in ischemic stroke
por: Cui, Yu, et al.
Publicado: (2022)

Endovascular thrombectomy in anterior circulation stroke and clinical value of bridging with intravenous thrombolysis
por: Balodis, Arturs, et al.
Publicado: (2018)

Cell free DNA: A Novel Predictor of Neurological Outcome after Intravenous Thrombolysis and/or Mechanical Thrombectomy in Acute Ischemic Stroke Patients
por: Vajpeyee, Atulabh, et al.
Publicado: (2018)

Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management
por: Ramiro, Laura, et al.
Publicado: (2018)

MRI-Based Predictors of Hemorrhagic Transformation in Patients With Stroke Treated by Intravenous Thrombolysis
por: El Nawar, Rody, et al.
Publicado: (2019)

Saudi neurology residents' knowledge and attitudes toward intravenous thrombolysis in patients with acute ischemic stroke
por: Alharbi, Fatimah Ali, et al.
Publicado: (2020)

Importance of Angiogenin and Endothelial Progenitor Cells After Rehabilitation Both in Ischemic Stroke Patients and in a Mouse Model of Cerebral Ischemia
por: Gabriel-Salazar, Marina, et al.
Publicado: (2018)

Intravenous thrombolysis for bioprosthetic valve thrombosis
por: Adrichem, Rik, et al.
Publicado: (2023)

Impact of Stress Hyperglycemia on Early Neurological Deterioration in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis
por: Wang, Ling, et al.
Publicado: (2022)

Perfusion-diffusion Mismatch Predicts Early Neurological Deterioration in Anterior Circulation Infarction without Thrombolysis
por: Hsu, Chia-Yu, et al.
Publicado: (2015)

Intravenous thrombolysis is more safe and effective for posterior circulation stroke: Data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
por: Tong, Xu, et al.
Publicado: (2016)

High neutrophil‐to‐lymphocyte ratio is a predictor of poor short‐term outcome in patients with mild acute ischemic stroke receiving intravenous thrombolysis
por: Liu, Yong‐Lin, et al.
Publicado: (2020)

Effect of intravenous thrombolysis with alteplase on clinical efficacy, inflammatory factors, and neurological function in patients with acute cerebral infarction
por: Wang, Jinhua, et al.
Publicado: (2021)

Impact of glycosylated hemoglobin on early neurological deterioration in acute mild ischemic stroke patients treated with intravenous thrombolysis
por: Han, Lin, et al.
Publicado: (2023)

Influencing factors of early dramatic recovery of neurological function after intravenous thrombolysis in patients with branch atheromatous disease
por: Meng, Yuanyuan, et al.
Publicado: (2023)

CNS-LAND score: predicting early neurological deterioration after intravenous thrombolysis based on systemic responses and injury
por: Jin, Huijuan, et al.
Publicado: (2023)

Blood Biomarkers in Cardioembolic Stroke
por: García-Berrocoso, Teresa, et al.
Publicado: (2010)

Age and Stroke Severity: Hazards for Intravenous Thrombolysis?
por: Long, Chuyan, et al.
Publicado: (2015)

“Calcified Clot March” after Intravenous Thrombolysis
por: Agarwal, Vivek, et al.
Publicado: (2020)

Intravenous Thrombolysis for a Stroke Mimic Patient
por: Nguyen, Lilly, et al.
Publicado: (2021)

Bridging intravenous thrombolysis in patients with atrial fibrillation
por: Mujanovic, Adnan, et al.
Publicado: (2022)

Risk factors are different for deep and lobar remote hemorrhages after intravenous thrombolysis
por: Prats-Sanchez, Luis, et al.
Publicado: (2017)

Insulin Resistance Is Associated With a Poor Response to Intravenous Thrombolysis in Acute Ischemic Stroke
por: Calleja, Ana I., et al.
Publicado: (2011)

Brain Perihematoma Genomic Profile Following Spontaneous Human Intracerebral Hemorrhage
por: Rosell, Anna, et al.
Publicado: (2011)

Predictors of Postthrombolysis Outcome and Symptomatic Postthrombolysis Hemorrhage following Intravenous Thrombolysis with Alteplase for Acute Ischemic Stroke
por: Das, Suman, et al.
Publicado: (2020)

Intravenous Thrombolysis in Chinese Patients with Different Subtype of Mild Stroke: Thrombolysis in Patients with Mild Stroke
por: Chen, Weiqi, et al.
Publicado: (2017)

Effects of time delays on the therapeutic outcomes of intravenous thrombolysis for acute ischemic stroke in the posterior circulation: An observational study
por: Huang, Qiang, et al.
Publicado: (2019)

What guides decision-making on intravenous thrombolysis in acute vestibular syndrome and suspected ischemic stroke in the posterior circulation?
por: Machner, Björn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2r7dahpeun63ic175sji8203d1